chitosan has been researched along with enkephalin, leucine-2-alanine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, HA; Chan, PH; Chen, Y; Siddalingappa, B | 1 |
| Biggiogera, M; Colonna, C; Conti, B; Dorati, R; Genta, I; Modena, T; Spedito, A | 1 |
| Biggiogera, M; Cisterna, B; Costanzo, M; Galimberti, V; Malatesta, M; Zancanaro, C | 1 |
3 other study(ies) available for chitosan and enkephalin, leucine-2-alanine
| Article | Year |
|---|---|
Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin.
Topics: beta-Cyclodextrins; Chemistry, Pharmaceutical; Chitosan; Dextran Sulfate; Dosage Forms; Drug Delivery Systems; Enkephalin, Leucine-2-Alanine; Molecular Weight; Nanoparticles; Particle Size | 2008 |
Induction of an in vitro reversible hypometabolism through chitosan-based nanoparticles.
Topics: Chitosan; Delayed-Action Preparations; Drug Carriers; Enkephalin, Leucine-2-Alanine; HeLa Cells; Humans; Nanoparticles | 2011 |
Chitosan nanoparticles are efficient carriers for delivering biodegradable drugs to neuronal cells.
Topics: Animals; Biological Transport; Cells, Cultured; Chitosan; Drug Carriers; Enkephalin, Leucine-2-Alanine; Microscopy, Fluorescence; Nanoparticles; Neurons; Particle Size; Rats; Surface Properties | 2014 |